This information is disseminated under the sponsorship of the U.S. Department of Transportation
in the interest of information exchange.
The United States Government assumes no Liability for the contents or use thereof.
Atenolol |
| Description |
Atenolol is a beta-adrenergic receptor antagonist, “beta blocker,” used in the treatment of hypertension and certain arrhythmias. Plasma protein binding is 6-16%. |
| Therapeutic Low |
0.4000 |
| Therapeutic High |
0.8000 |
| Units |
ug/mL |
| Specimen |
B |
| Half Life Low |
7.00 |
| Half Life High |
0.00 |
| VOD Low |
1.00 |
| VOD High |
0.00 |
| Toxic Level |
2.000 |
| Lethal Level |
30.000 |
| Plasma to Whole Blood ratio |
0.90 |
| Warnings |
|